載入中
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
最新資料
US$8.84
+US$0.40 · +4.74%
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
前收盤價
US$8.84
+US$0.40 · +4.74%
盤中時間採用ET。市場資料可能有所延遲。
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
日內區間
目前US$8.84
52週區間
目前US$8.84
盤中時間採用ET。市場資料可能有所延遲。
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
日內區間
目前US$8.84
52週區間
目前US$8.84
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 4052萬 USD | 3774.5萬 USD | 3668.4萬 USD | 4142萬 USD | 3689.3萬 USD |
| 銷貨成本 | 2707.9萬 USD | 3051.4萬 USD | 2638.8萬 USD | 2394.4萬 USD | 1927.2萬 USD |
| 毛利 | 1344.1萬 USD | 723.1萬 USD | 1029.6萬 USD | 1747.6萬 USD | 1762.1萬 USD |
| 研究與開發 | 219.7萬 USD | 275.9萬 USD | 556.7萬 USD | 773.7萬 USD | 431.2萬 USD |
| 銷售、一般及管理費用 | 2707.2萬 USD | 2947萬 USD | 3478萬 USD | 3744.9萬 USD | 2416.9萬 USD |
| 營業費用 | 3041.7萬 USD | 3337.7萬 USD | 4585.9萬 USD | 6713.5萬 USD | 2962.9萬 USD |
| 利息收入 | — | — | — | 21.3萬 USD | — |
| 利息支出 | 71萬 USD | 68.7萬 USD | 83.3萬 USD | — | 58.9萬 USD |
| 折舊和攤銷 | 634.2萬 USD | 657.8萬 USD | 566萬 USD | 316.5萬 USD | 288.3萬 USD |
| 營業利益 | −1697.6萬 USD | −2614.6萬 USD | −3556.3萬 USD | −4965.9萬 USD | −1200.8萬 USD |
| 淨利 | −1725.9萬 USD | −2674.5萬 USD | −3678萬 USD | −4746.8萬 USD | −980.3萬 USD |
公司資料更新於 2026年10月11日。
第三方分析師預期可能變動，並非 GoAI 建議。
評級樣本有限，僅3項
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1060.74萬0.00%2.3兆 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM263.73萬0.00%787.4億 USD0.19%US$278.94+0.49%
Vanguard Extended Market ETFVXF87.39萬0.00%954億 USD0.05%US$235+0.80%
iShares Biotechnology ETFIBB71.49萬0.01%108.2億 USD0.44%US$206.49+3.00%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM52萬0.44%1.17億 USD0.73%US$15.9402+0.25%
Vanguard Russell 2000 ETFVTWO46.88萬0.00%180億 USD0.06%US$112.66+0.50%
Avantis U.S. Small Cap Equity ETFAVSC31.01萬0.01%30.82億 USD0.25%US$69.98+0.03%
iShares Micro-Cap ETFIWC30.17萬0.02%13.17億 USD0.60%US$183+0.11%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Biotechnology ETFIBBEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMVanguard Russell 2000 ETFVTWOAvantis U.S. Small Cap Equity ETFAVSCiShares Micro-Cap ETFIWCAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
